Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Increase in Hldg in Norplat

27 Feb 2006 09:17

Ovoca Gold PLC27 February 2006 Ovoca Gold plc ("Ovoca") OVOCA INCREASES SHAREHOLDING IN NORPLAT TO 86% Ovoca (OVG.L, London; OVX.IE, Dublin) announces that today it has acquired anadditional 12,112,543 ordinary shares in its subsidiary Norplat Limited, ("Norplat") in consideration of the issue of 13,323,798 new Ovoca ordinary sharesof €0.025 each ("Ordinary Shares"). As a result, Ovoca now has 135,411,040 Ordinary Shares in issue and hasincreased its shareholding in Norplat to 86%. As part of this transaction, the following directors and their connected personshave disposed of their remaining shareholding in Norplat and their previous andcurrent shareholding in the Company is as follows: Previous Previous Current Current Holding % Holding % Roger Tuner 2,864,438 2.35% 3,850,001 2.84%Barrie Oakes 3,719,889 3.05% 4,994,108 3.69%Guy Pas 3,964,536 3.25% 5,555,000 4.10% Under the terms of the May 2005 Norplat Option Agreement, Ovoca retains theright to acquire the remaining ordinary shares in Norplat which it does notalready own, on the same terms, until 10 May 2007 (i.e. eleven new OrdinaryShares for every ten Norplat ordinary shares). Commenting on this increase in Ovoca's shareholding in Norplat, Chief ExecutiveBarrie Oakes stated "Following results from the 2005 drilling and trenchingprogramme in the Kola region of Russia, the acquisition of additional licensesin the area to cover more highly prospective ground and the exercising of theoutstanding Norplat warrants the board has decided that this is an opportunetime for Ovoca to increase its equity holding in Norplat." For further information please contact Barrie Oakes CEO +44 (0)795 1139266 Roger Turner Chairman+44 (0)7739 092 813 Kevin Lynch Nabarro Wells & Co Limited +44 (0)207710 7400John Frain Davy Corporate Finance +353 (0)1 679 6363 Tom McCormack Connexions PR +353 (0)86245 4215 +353 (0)1 230 3015 This announcement has been issued through the Companies Announcement Service of The Irish Stock Exchange This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Feb 20267:00 amRNSChange of Name
28th Jan 20268:00 amRNSReadmission - Ovoca Bio PLC
28th Jan 20267:00 amRNSFirst Day of Dealings on AIM
27th Jan 20262:32 pmRNSResult of Meeting
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20257:00 amRNSNotice of AGM
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSNotice of AGM
13th Nov 20257:00 amRNSChange of Broker
30th Sep 20251:09 pmRNSReplacement Half Year Report
30th Sep 20257:00 amRNSHalf-year Report
26th Jun 20257:00 amRNSPublication of 2024 Annual Report
5th Jun 20257:00 amRNSDelisting from Euronext Growth Exchange
7th May 20257:30 amRNSSuspension - Ovoca Bio plc
7th May 20257:00 amRNSProposed Acquisition, Disposal & Reverse Takeover
3rd Mar 20252:00 pmRNSManagement Changes
18th Dec 20246:00 pmRNSResult of AGM
18th Nov 20247:00 amRNSNotice of AGM
11th Oct 20245:30 pmRNSHolding(s) in Company
9th Oct 20245:45 pmRNSSale of Treasury Shares
25th Sep 20247:00 amRNSHalf-year Report
2nd Sep 20242:30 pmRNSConsultancy Agreement
15th Jul 20247:00 amRNSDirector/PDMR Shareholding
15th Jul 20247:00 amRNSDirectorate Change
28th Jun 20247:00 amRNSAnnual Financial Report
23rd Jan 20247:00 amRNSHolding(s) in Company
1st Dec 202312:00 pmRNSResult of AGM
7th Nov 20239:15 amRNSNotice of AGM
28th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSSummary Results of Phase II Study for Orenetide
30th Jun 20237:00 amRNSAnnual Financial Report
12th Jun 20237:00 amRNSUpdate on Completion Timelines for Phase II Study
16th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 20239:05 amRNSSecond Price Monitoring Extn
16th Mar 20239:00 amRNSPrice Monitoring Extension
8th Mar 20237:00 amRNSDisposal of Russian Assets
14th Feb 20234:41 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
28th Oct 20227:00 amRNSResult of AGM
6th Oct 20222:30 pmRNSNotice of AGM
30th Sep 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.